These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1605292)
61. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial. Arrenbrecht S; Boermans AJ Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492 [TBL] [Abstract][Full Text] [Related]
62. An oestrogen patch for hormone replacement therapy. Drug Ther Bull; 1989 Nov; 27(24):93-5. PubMed ID: 2519318 [No Abstract] [Full Text] [Related]
63. Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy. Raudaskoski T; Knip M; Laatikainen T Menopause; 1998; 5(4):217-22. PubMed ID: 9872487 [TBL] [Abstract][Full Text] [Related]
64. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens]. Winkler UH; Krämer R; Kwee B; Schindler AE Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837 [TBL] [Abstract][Full Text] [Related]
65. Safety and benefit considerations for menopausal hormone therapy. Pickar JH; Archer DF; Kagan R; Pinkerton JV; Taylor HS Expert Opin Drug Saf; 2017 Aug; 16(8):941-954. PubMed ID: 28664754 [TBL] [Abstract][Full Text] [Related]
66. Menorest: a clinical overview. Wren B Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S27-9. PubMed ID: 8666124 [TBL] [Abstract][Full Text] [Related]
67. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency. Whittington R; Faulds D Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233 [TBL] [Abstract][Full Text] [Related]
68. Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis. Balfour JA; McTavish D Drugs Aging; 1992; 2(6):487-507. PubMed ID: 1493353 [TBL] [Abstract][Full Text] [Related]
69. Adverse skin reactions to transdermal oestradiol in tropical climate. A comparative study of skin tolerance after using oestradiol patch and gel in Thai postmenopausal women. Sentrakul P; Chompootaweep S; Sintupak S; Tasanapradit P; Tunsaringkarn K; Dusitsin N Maturitas; 1991 Jun; 13(2):151-4. PubMed ID: 1833610 [TBL] [Abstract][Full Text] [Related]
70. Comparison of gel and patch estradiol replacement in Brazil, a tropical country. Travassos de Figueiredo Alves ; Amélia Sobreira Gomes M; Clapauch R Maturitas; 2000 Jul; 36(1):69-74. PubMed ID: 10989244 [TBL] [Abstract][Full Text] [Related]
71. Skin reactions with transdermal estradiol therapy in a tropical environment. Bhathena RK; Anklesaria BS; Ganatra AM Int J Gynaecol Obstet; 1998 Feb; 60(2):177-9. PubMed ID: 9509960 [No Abstract] [Full Text] [Related]
72. An Australian experience of transdermal oestradiol patches in a subtropical climate. O'Neill S; Kirkegard Y Aust N Z J Obstet Gynaecol; 1993 Aug; 33(3):327-9. PubMed ID: 8304906 [TBL] [Abstract][Full Text] [Related]
73. Use of two types of estradiol-releasing skin patches for menopausal patients in a tropical climate. McCarthy T; Dramusic V; Ratnam S Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):2005-10. PubMed ID: 1605292 [TBL] [Abstract][Full Text] [Related]
74. Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women. Naunton M; Al Hadithy AF; Brouwers JR; Archer DF Menopause; 2006; 13(3):517-27. PubMed ID: 16735950 [TBL] [Abstract][Full Text] [Related]